Andere Kunden interessierten sich auch für
![Exploring the Adoption of Implantable Brain Stimulation Into Standard of Care for Central Nervous System Disorders]( "Exploring the Adoption of Implantable Brain Stimulation Into Standard of Care for Central Nervous System Disorders")
Exploring the Adoption of Implantable Brain Stimulation Into Standard of Care for Central Nervous System Disorders25,99 €![Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression]( "Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression")
Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression52,99 €![Advancing Gene-Targeted Therapies for Central Nervous System Disorders]( "Advancing Gene-Targeted Therapies for Central Nervous System Disorders")
Advancing Gene-Targeted Therapies for Central Nervous System Disorders73,99 €![Novel Molecular Targets for Mood Disorders and Psychosis]( "Novel Molecular Targets for Mood Disorders and Psychosis")
Novel Molecular Targets for Mood Disorders and Psychosis51,99 €![Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders]( "Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders")
Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders19,99 €![Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders]( "Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders")
Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders62,99 €![Harnessing Mobile Devices for Nervous System Disorders]( "Harnessing Mobile Devices for Nervous System Disorders")
Harnessing Mobile Devices for Nervous System Disorders65,99 €
Despite substantial advances in developing treatments for the serious illnesses that affect people worldwide, there remains a tremendous unmet need in the treatment of complex neurologic diseases, including neuropsychiatric and neurodegenerative disorders. Chief among the challenges that have hindered the development of therapeutics for central nervous system (CNS) disorders is the blood-brain barrier (BBB). The Forum on Neuroscience and Nervous System Disorders of the National Academies of Sciences, Engineering, and Medicine convened a workshop to explore the challenges associated with the BBB that have thus far stymied development of CNS drugs, examine new technologies that could address these challenges, and highlight potential opportunities for moving the field forward. This publication summarizes the presentations and discussions from the workshop.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.